Skip to main content
Erschienen in:

02.03.2021 | Review Article

Innovations in Cardiac Implantable Electronic Devices

verfasst von: Khurrum Khan, Jitae A. Kim, Andra Gurgu, Muzamil Khawaja, Dragos Cozma, Mihail G. Chelu

Erschienen in: Cardiovascular Drugs and Therapy | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Cardiac implantable electronic devices (CIEDs) are essential for the management of a variety of cardiac conditions, including tachyarrhythmias, bradyarrhythmias, and medically refractory heart failure (HF). Recent advancements in CIED technology have led to innovative solutions that overcome shortcomings associated with traditional devices or address unmet needs. Leadless pacemakers, subcutaneous implantable cardioverter defibrillators (ICDs), and extravascular ICDs eliminate lead-related complications common with conventional pacemakers or ICDs. Conduction system pacing (His bundle pacing and left bundle branch pacing) is a more physiologic method of pacing and avoids the deleterious consequences associated with long-term right ventricular pacing. For HF-related devices, cardiac contractility modulation is an emerging therapy that bridges a gap for many patients ineligible for cardiac resynchronization therapy and has been shown to improve HF symptoms and decrease hospitalizations and mortality in select patients. Implantable pulmonary artery pressure monitors help guide HF management and reduce hospitalizations. Lastly, new phrenic nerve stimulating devices are being utilized to treat central sleep apnea, a common comorbidity associated with HF. While further long-term studies are still underway for many of these new technologies, it is anticipated that these devices will become indispensable therapeutics in the expanding cardiovascular armamentarium.
Literatur
1.
Zurück zum Zitat Larsson B, Elmqvist H, Rydén L, Schüller H. Lessons from the first patient with an implanted pacemaker: 1958-2001. Pacing Clin Electrophysiol. 2003;26(1 Pt 1):114–24.PubMedCrossRef Larsson B, Elmqvist H, Rydén L, Schüller H. Lessons from the first patient with an implanted pacemaker: 1958-2001. Pacing Clin Electrophysiol. 2003;26(1 Pt 1):114–24.PubMedCrossRef
2.
Zurück zum Zitat Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009--a World Society of Arrhythmia’s project. Pacing Clin Electrophysiol. 2011;34(8):1013–27.PubMedCrossRef Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009--a World Society of Arrhythmia’s project. Pacing Clin Electrophysiol. 2011;34(8):1013–27.PubMedCrossRef
3.
Zurück zum Zitat Udo EO, Zuithoff NP, van Hemel NM, et al. Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm. 2012;9(5):728–35.PubMedCrossRef Udo EO, Zuithoff NP, van Hemel NM, et al. Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm. 2012;9(5):728–35.PubMedCrossRef
4.
Zurück zum Zitat Tops LF, Schalij MJ, Bax JJ. The effects of right ventricular apical pacing on ventricular function and dyssynchrony implications for therapy. J Am Coll Cardiol. 2009;54(9):764–76.PubMedCrossRef Tops LF, Schalij MJ, Bax JJ. The effects of right ventricular apical pacing on ventricular function and dyssynchrony implications for therapy. J Am Coll Cardiol. 2009;54(9):764–76.PubMedCrossRef
5.
Zurück zum Zitat Udo EO, van Hemel NM, Zuithoff NP, Doevendans PA, Moons KG. Risk of heart failure- and cardiac death gradually increases with more right ventricular pacing. Int J Cardiol. 2015;185:95–100.PubMedCrossRef Udo EO, van Hemel NM, Zuithoff NP, Doevendans PA, Moons KG. Risk of heart failure- and cardiac death gradually increases with more right ventricular pacing. Int J Cardiol. 2015;185:95–100.PubMedCrossRef
6.
Zurück zum Zitat Kirkfeldt RE, Johansen JB, Nohr EA, Jørgensen OD, Nielsen JC. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2014;35(18):1186–94.PubMedCrossRef Kirkfeldt RE, Johansen JB, Nohr EA, Jørgensen OD, Nielsen JC. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2014;35(18):1186–94.PubMedCrossRef
7.
Zurück zum Zitat Reddy VY, Knops RE, Sperzel J, Miller MA, Petru J, Simon J, et al. Permanent leadless cardiac pacing: results of the LEADLESS trial. Circulation. 2014;129(14):1466–71.PubMedCrossRef Reddy VY, Knops RE, Sperzel J, Miller MA, Petru J, Simon J, et al. Permanent leadless cardiac pacing: results of the LEADLESS trial. Circulation. 2014;129(14):1466–71.PubMedCrossRef
8.
Zurück zum Zitat Kotsakou M, Kioumis I, Lazaridis G, Pitsiou G, Lampaki S, Papaiwannou A, et al. Pacemaker insertion. Ann Transl Med. 2015;3(3):42.PubMedPubMedCentral Kotsakou M, Kioumis I, Lazaridis G, Pitsiou G, Lampaki S, Papaiwannou A, et al. Pacemaker insertion. Ann Transl Med. 2015;3(3):42.PubMedPubMedCentral
9.
Zurück zum Zitat Sharma PS, Vijayaraman P, Ellenbogen KA. Permanent His bundle pacing: shaping the future of physiological ventricular pacing. Nat Rev Cardiol. 2020;17(1):22–36.PubMedCrossRef Sharma PS, Vijayaraman P, Ellenbogen KA. Permanent His bundle pacing: shaping the future of physiological ventricular pacing. Nat Rev Cardiol. 2020;17(1):22–36.PubMedCrossRef
10.
Zurück zum Zitat Vijayaraman P, Subzposh FA, Naperkowski A, Panikkath R, John K, Mascarenhas V, et al. Prospective evaluation of feasibility and electrophysiologic and echocardiographic characteristics of left bundle branch area pacing. Heart Rhythm. 2019;16(12):1774–82.PubMedCrossRef Vijayaraman P, Subzposh FA, Naperkowski A, Panikkath R, John K, Mascarenhas V, et al. Prospective evaluation of feasibility and electrophysiologic and echocardiographic characteristics of left bundle branch area pacing. Heart Rhythm. 2019;16(12):1774–82.PubMedCrossRef
11.
Zurück zum Zitat Padala Santosh K, Master Vivak M, Terricabras M, et al. Initial experience, safety, and feasibility of left bundle branch area pacing. JACC: Clin Electrophysiol. 2020;6(14):1773–82. Padala Santosh K, Master Vivak M, Terricabras M, et al. Initial experience, safety, and feasibility of left bundle branch area pacing. JACC: Clin Electrophysiol. 2020;6(14):1773–82.
12.
Zurück zum Zitat Duray GZ, Ritter P, El-Chami M, et al. Long-term performance of a transcatheter pacing system: 12-month results from the Micra Transcatheter Pacing Study. Heart Rhythm. 2017;14(5):702–9.PubMedCrossRef Duray GZ, Ritter P, El-Chami M, et al. Long-term performance of a transcatheter pacing system: 12-month results from the Micra Transcatheter Pacing Study. Heart Rhythm. 2017;14(5):702–9.PubMedCrossRef
13.
Zurück zum Zitat Bhatt AG, Musat DL, Milstein N, et al. The efficacy of his bundle pacing: lessons learned from implementation for the first time at an experienced electrophysiology center. JACC: Clin Electrophysiol. 2018;4(11):1397–406. Bhatt AG, Musat DL, Milstein N, et al. The efficacy of his bundle pacing: lessons learned from implementation for the first time at an experienced electrophysiology center. JACC: Clin Electrophysiol. 2018;4(11):1397–406.
14.
Zurück zum Zitat Lakkireddy D, Knops R, Atwater B, Neuzil P, Ip J, Gonzalez E, et al. A worldwide experience of the management of battery failures and chronic device retrieval of the Nanostim leadless pacemaker. Heart Rhythm. 2017;14(12):1756–63.PubMedCrossRef Lakkireddy D, Knops R, Atwater B, Neuzil P, Ip J, Gonzalez E, et al. A worldwide experience of the management of battery failures and chronic device retrieval of the Nanostim leadless pacemaker. Heart Rhythm. 2017;14(12):1756–63.PubMedCrossRef
15.
Zurück zum Zitat Singh JP, Abraham WT, Auricchio A, et al. Design and rationale for the Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in non-responders and previously untreatable patients (SOLVE-CRT) trial. Am Heart J. 2019;217:13–22.PubMedCrossRef Singh JP, Abraham WT, Auricchio A, et al. Design and rationale for the Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in non-responders and previously untreatable patients (SOLVE-CRT) trial. Am Heart J. 2019;217:13–22.PubMedCrossRef
16.
Zurück zum Zitat Della Rocca DG, Gianni C, Di Biase L, Natale A, Al-Ahmad A. Leadless pacemakers: state of the art and future perspectives. Card Electrophysiol Clin. 2018;10(1):17–29.PubMedCrossRef Della Rocca DG, Gianni C, Di Biase L, Natale A, Al-Ahmad A. Leadless pacemakers: state of the art and future perspectives. Card Electrophysiol Clin. 2018;10(1):17–29.PubMedCrossRef
17.
Zurück zum Zitat Chinitz L, Ritter P, Khelae SK, Iacopino S, Garweg C, Grazia-Bongiorni M, et al. Accelerometer-based atrioventricular synchronous pacing with a ventricular leadless pacemaker: results from the Micra atrioventricular feasibility studies. Heart Rhythm. 2018;15(9):1363–71.PubMedCrossRef Chinitz L, Ritter P, Khelae SK, Iacopino S, Garweg C, Grazia-Bongiorni M, et al. Accelerometer-based atrioventricular synchronous pacing with a ventricular leadless pacemaker: results from the Micra atrioventricular feasibility studies. Heart Rhythm. 2018;15(9):1363–71.PubMedCrossRef
18.
Zurück zum Zitat Steinwender C, Khelae SK, Garweg C, Chan JYS, Ritter P, Johansen JB, et al. Atrioventricular synchronous pacing using a leadless ventricular pacemaker: results from the MARVEL 2 study. JACC Clin Electrophysiol. 2020;6(1):94–106.PubMedCrossRef Steinwender C, Khelae SK, Garweg C, Chan JYS, Ritter P, Johansen JB, et al. Atrioventricular synchronous pacing using a leadless ventricular pacemaker: results from the MARVEL 2 study. JACC Clin Electrophysiol. 2020;6(1):94–106.PubMedCrossRef
19.
Zurück zum Zitat Reynolds D, Duray GZ, Omar R, Soejima K, Neuzil P, Zhang S, et al. A leadless intracardiac transcatheter pacing system. N Engl J Med. 2015;374(6):533–41.PubMedCrossRef Reynolds D, Duray GZ, Omar R, Soejima K, Neuzil P, Zhang S, et al. A leadless intracardiac transcatheter pacing system. N Engl J Med. 2015;374(6):533–41.PubMedCrossRef
20.
Zurück zum Zitat Roberts PR, Clementy N, Al Samadi F, et al. A leadless pacemaker in the real-world setting: the Micra Transcatheter Pacing System Post-Approval Registry. Heart Rhythm. 2017;14(9):1375–9.PubMedCrossRef Roberts PR, Clementy N, Al Samadi F, et al. A leadless pacemaker in the real-world setting: the Micra Transcatheter Pacing System Post-Approval Registry. Heart Rhythm. 2017;14(9):1375–9.PubMedCrossRef
21.
Zurück zum Zitat El-Chami MF, Al-Samadi F, Clementy N, et al. Updated performance of the Micra transcatheter pacemaker in the real-world setting: a comparison to the investigational study and a transvenous historical control. Heart Rhythm. 2018;15(12):1800–7.PubMedCrossRef El-Chami MF, Al-Samadi F, Clementy N, et al. Updated performance of the Micra transcatheter pacemaker in the real-world setting: a comparison to the investigational study and a transvenous historical control. Heart Rhythm. 2018;15(12):1800–7.PubMedCrossRef
22.
Zurück zum Zitat Ausubel K, Steingart RM, Shimshi M, Klementowicz P, Furman S. Maintenance of exercise stroke volume during ventricular versus atrial synchronous pacing: role of contractility. Circulation. 1985;72(5):1037–43.PubMedCrossRef Ausubel K, Steingart RM, Shimshi M, Klementowicz P, Furman S. Maintenance of exercise stroke volume during ventricular versus atrial synchronous pacing: role of contractility. Circulation. 1985;72(5):1037–43.PubMedCrossRef
23.
Zurück zum Zitat Piccini JP, Stromberg K, Jackson KP, Kowal RC, Duray GZ, el-Chami MF, et al. Patient selection, pacing indications, and subsequent outcomes with de novo leadless single-chamber VVI pacing. Europace. 2019;21(11):1686–93.PubMedCrossRef Piccini JP, Stromberg K, Jackson KP, Kowal RC, Duray GZ, el-Chami MF, et al. Patient selection, pacing indications, and subsequent outcomes with de novo leadless single-chamber VVI pacing. Europace. 2019;21(11):1686–93.PubMedCrossRef
24.
Zurück zum Zitat Bereuter L, Gysin M, Kueffer T, Kucera M, Niederhauser T, Fuhrer J, et al. Leadless dual-chamber pacing: a novel communication method for wireless pacemaker synchronization. JACC Basic Transl Sci. 2018;3(6):813–23.PubMedPubMedCentralCrossRef Bereuter L, Gysin M, Kueffer T, Kucera M, Niederhauser T, Fuhrer J, et al. Leadless dual-chamber pacing: a novel communication method for wireless pacemaker synchronization. JACC Basic Transl Sci. 2018;3(6):813–23.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Bereuter L, Niederhauser T, Kucera M, Loosli D, Steib I, Schildknecht M, et al. Leadless cardiac resynchronization therapy: an in vivo proof-of-concept study of wireless pacemaker synchronization. Heart Rhythm. 2019;16(6):936–42.PubMedCrossRef Bereuter L, Niederhauser T, Kucera M, Loosli D, Steib I, Schildknecht M, et al. Leadless cardiac resynchronization therapy: an in vivo proof-of-concept study of wireless pacemaker synchronization. Heart Rhythm. 2019;16(6):936–42.PubMedCrossRef
26.
Zurück zum Zitat Montemerlo E, Pozzi M, De Ceglia S, et al. First-in-man fully leadless transvenous CRT-P with a transseptal implant of WISE-CRT(®) system and Micra(®) PM. Pacing Clin Electrophysiol. 2019;42(11):1489–92.PubMedCrossRef Montemerlo E, Pozzi M, De Ceglia S, et al. First-in-man fully leadless transvenous CRT-P with a transseptal implant of WISE-CRT(®) system and Micra(®) PM. Pacing Clin Electrophysiol. 2019;42(11):1489–92.PubMedCrossRef
27.
Zurück zum Zitat Tjong FVY, Brouwer TF, Koop B, Soltis B, Shuros A, Schmidt B, et al. Acute and 3-month performance of a communicating leadless antitachycardia pacemaker and subcutaneous implantable defibrillator. JACC Clin Electrophysiol. 2017;3(13):1487–98.PubMedCrossRef Tjong FVY, Brouwer TF, Koop B, Soltis B, Shuros A, Schmidt B, et al. Acute and 3-month performance of a communicating leadless antitachycardia pacemaker and subcutaneous implantable defibrillator. JACC Clin Electrophysiol. 2017;3(13):1487–98.PubMedCrossRef
28.
Zurück zum Zitat Riedlbauchová L, Kautzner J, Hatala R, Buckingham TA. Is right ventricular outflow tract pacing an alternative to left ventricular/biventricular pacing? Pacing Clin Electrophysiol. 2004;27(6 Pt 2):871–7.PubMedCrossRef Riedlbauchová L, Kautzner J, Hatala R, Buckingham TA. Is right ventricular outflow tract pacing an alternative to left ventricular/biventricular pacing? Pacing Clin Electrophysiol. 2004;27(6 Pt 2):871–7.PubMedCrossRef
29.
Zurück zum Zitat Cano O, Osca J, Sancho-Tello MJ, Sánchez JM, Ortiz V, Castro JE, et al. Comparison of effectiveness of right ventricular septal pacing versus right ventricular apical pacing. Am J Cardiol. 2010;105(10):1426–32.PubMedCrossRef Cano O, Osca J, Sancho-Tello MJ, Sánchez JM, Ortiz V, Castro JE, et al. Comparison of effectiveness of right ventricular septal pacing versus right ventricular apical pacing. Am J Cardiol. 2010;105(10):1426–32.PubMedCrossRef
30.
Zurück zum Zitat Deshmukh P, Casavant DA, Romanyshyn M, Anderson K. Permanent, direct His-bundle pacing: a novel approach to cardiac pacing in patients with normal His-Purkinje activation. Circulation. 2000;101(8):869–77.PubMedCrossRef Deshmukh P, Casavant DA, Romanyshyn M, Anderson K. Permanent, direct His-bundle pacing: a novel approach to cardiac pacing in patients with normal His-Purkinje activation. Circulation. 2000;101(8):869–77.PubMedCrossRef
31.
Zurück zum Zitat James TN. Structure and function of the sinus node, AV node and His bundle of the human heart: part I-structure. Prog Cardiovasc Dis. 2002;45(3):235–67.PubMedCrossRef James TN. Structure and function of the sinus node, AV node and His bundle of the human heart: part I-structure. Prog Cardiovasc Dis. 2002;45(3):235–67.PubMedCrossRef
32.
Zurück zum Zitat Ali N, Keene D, Arnold A, et al. His bundle pacing: A new frontier in the treatment of heart failure. Arrhythmia Electrophysiol Rev. 2018;7(2):103–10.CrossRef Ali N, Keene D, Arnold A, et al. His bundle pacing: A new frontier in the treatment of heart failure. Arrhythmia Electrophysiol Rev. 2018;7(2):103–10.CrossRef
33.
Zurück zum Zitat Scherlag BJ, Lau SH, Helfant RH, et al. Catheter technique for recording His bundle activity in man. Circulation. 1969;39(1):13–8.PubMedCrossRef Scherlag BJ, Lau SH, Helfant RH, et al. Catheter technique for recording His bundle activity in man. Circulation. 1969;39(1):13–8.PubMedCrossRef
34.
Zurück zum Zitat Occhetta E, Bortnik M, Marino P. Permanent parahisian pacing. Indian Pacing Electrophysiol J. 2007;7(2):110–25.PubMedPubMedCentral Occhetta E, Bortnik M, Marino P. Permanent parahisian pacing. Indian Pacing Electrophysiol J. 2007;7(2):110–25.PubMedPubMedCentral
35.
Zurück zum Zitat Barba-Pichardo R, Moriña-Vázquez P, Venegas-Gamero J, Maroto-Monserrat F, Cid-Cumplido M, Herrera-Carranza M. Permanent His-bundle pacing in patients with infra-Hisian atrioventricular block. Rev Esp Cardiol. 2006;59(6):553–8.PubMedCrossRef Barba-Pichardo R, Moriña-Vázquez P, Venegas-Gamero J, Maroto-Monserrat F, Cid-Cumplido M, Herrera-Carranza M. Permanent His-bundle pacing in patients with infra-Hisian atrioventricular block. Rev Esp Cardiol. 2006;59(6):553–8.PubMedCrossRef
36.
Zurück zum Zitat Kronborg MB, Mortensen PT, Gerdes JC, Jensen HK, Nielsen JC. His and para-His pacing in AV block: feasibility and electrocardiographic findings. J Interv Card Electrophysiol. 2011;31(3):255–62.PubMedCrossRef Kronborg MB, Mortensen PT, Gerdes JC, Jensen HK, Nielsen JC. His and para-His pacing in AV block: feasibility and electrocardiographic findings. J Interv Card Electrophysiol. 2011;31(3):255–62.PubMedCrossRef
37.
Zurück zum Zitat Zanon F, Bacchiega E, Rampin L, Aggio S, Baracca E, Pastore G, et al. Direct His bundle pacing preserves coronary perfusion compared with right ventricular apical pacing: a prospective, cross-over mid-term study. Europace. 2008;10(5):580–7.PubMedCrossRef Zanon F, Bacchiega E, Rampin L, Aggio S, Baracca E, Pastore G, et al. Direct His bundle pacing preserves coronary perfusion compared with right ventricular apical pacing: a prospective, cross-over mid-term study. Europace. 2008;10(5):580–7.PubMedCrossRef
38.
Zurück zum Zitat Catanzariti D, Maines M, Manica A, Angheben C, Varbaro A, Vergara G. Permanent His-bundle pacing maintains long-term ventricular synchrony and left ventricular performance, unlike conventional right ventricular apical pacing. Europace. 2013;15(4):546–53.PubMedCrossRef Catanzariti D, Maines M, Manica A, Angheben C, Varbaro A, Vergara G. Permanent His-bundle pacing maintains long-term ventricular synchrony and left ventricular performance, unlike conventional right ventricular apical pacing. Europace. 2013;15(4):546–53.PubMedCrossRef
39.
Zurück zum Zitat Vijayaraman P, Chung MK, Dandamudi G, Upadhyay GA, Krishnan K, Crossley G, et al. His bundle pacing. J Am Coll Cardiol. 2018;72(8):927–47.PubMedCrossRef Vijayaraman P, Chung MK, Dandamudi G, Upadhyay GA, Krishnan K, Crossley G, et al. His bundle pacing. J Am Coll Cardiol. 2018;72(8):927–47.PubMedCrossRef
40.
Zurück zum Zitat Abdelrahman M, Subzposh FA, Beer D, Durr B, Naperkowski A, Sun H, et al. Clinical outcomes of his bundle pacing compared to right ventricular pacing. J Am Coll Cardiol. 2018;71(20):2319–30.PubMedCrossRef Abdelrahman M, Subzposh FA, Beer D, Durr B, Naperkowski A, Sun H, et al. Clinical outcomes of his bundle pacing compared to right ventricular pacing. J Am Coll Cardiol. 2018;71(20):2319–30.PubMedCrossRef
41.
Zurück zum Zitat Upadhyay GA, Vijayaraman P, Nayak HM, Verma N, Dandamudi G, Sharma PS, et al. His corrective pacing or biventricular pacing for cardiac resynchronization in heart failure. J Am Coll Cardiol. 2019;74(1):157–9.PubMedCrossRef Upadhyay GA, Vijayaraman P, Nayak HM, Verma N, Dandamudi G, Sharma PS, et al. His corrective pacing or biventricular pacing for cardiac resynchronization in heart failure. J Am Coll Cardiol. 2019;74(1):157–9.PubMedCrossRef
42.
Zurück zum Zitat Occhetta E, Bortnik M, Magnani A, Francalacci G, Piccinino C, Plebani L, et al. Prevention of ventricular desynchronization by permanent para-Hisian pacing after atrioventricular node ablation in chronic atrial fibrillation: a crossover, blinded, randomized study versus apical right ventricular pacing. J Am Coll Cardiol. 2006;47(10):1938–45.PubMedCrossRef Occhetta E, Bortnik M, Magnani A, Francalacci G, Piccinino C, Plebani L, et al. Prevention of ventricular desynchronization by permanent para-Hisian pacing after atrioventricular node ablation in chronic atrial fibrillation: a crossover, blinded, randomized study versus apical right ventricular pacing. J Am Coll Cardiol. 2006;47(10):1938–45.PubMedCrossRef
43.
Zurück zum Zitat Kronborg MB, Mortensen PT, Poulsen SH, Gerdes JC, Jensen HK, Nielsen JC. His or para-His pacing preserves left ventricular function in atrioventricular block: a double-blind, randomized, crossover study. Europace. 2014;16(8):1189–96.PubMedCrossRef Kronborg MB, Mortensen PT, Poulsen SH, Gerdes JC, Jensen HK, Nielsen JC. His or para-His pacing preserves left ventricular function in atrioventricular block: a double-blind, randomized, crossover study. Europace. 2014;16(8):1189–96.PubMedCrossRef
44.
Zurück zum Zitat Lewis AJM, Foley P, Whinnett Z, Keene D, Chandrasekaran B. His bundle pacing: a new strategy for physiological ventricular activation. J Am Heart Assoc. 2019;8(6):e010972.PubMedPubMedCentralCrossRef Lewis AJM, Foley P, Whinnett Z, Keene D, Chandrasekaran B. His bundle pacing: a new strategy for physiological ventricular activation. J Am Heart Assoc. 2019;8(6):e010972.PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Keene D, Arnold A, Shun-Shin MJ, Howard JP, Sohaib SMA, Moore P, et al. Rationale and design of the randomized multicentre His Optimized Pacing Evaluated for Heart Failure (HOPE-HF) trial. ESC Heart Fail. 2018;5(5):965–76.PubMedPubMedCentralCrossRef Keene D, Arnold A, Shun-Shin MJ, Howard JP, Sohaib SMA, Moore P, et al. Rationale and design of the randomized multicentre His Optimized Pacing Evaluated for Heart Failure (HOPE-HF) trial. ESC Heart Fail. 2018;5(5):965–76.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Tabrizi F, Englund A, Rosenqvist M, Wallentin L, Stenestrand U. Influence of left bundle branch block on long-term mortality in a population with heart failure. Eur Heart J. 2007;28(20):2449–55.PubMedCrossRef Tabrizi F, Englund A, Rosenqvist M, Wallentin L, Stenestrand U. Influence of left bundle branch block on long-term mortality in a population with heart failure. Eur Heart J. 2007;28(20):2449–55.PubMedCrossRef
47.
Zurück zum Zitat Huang W, Su L, Wu S, et al. A novel pacing strategy with low and stable output: pacing the left bundle branch immediately beyond the conduction block. Can J Cardiol. 2017;33(12):1736.e1–3.CrossRef Huang W, Su L, Wu S, et al. A novel pacing strategy with low and stable output: pacing the left bundle branch immediately beyond the conduction block. Can J Cardiol. 2017;33(12):1736.e1–3.CrossRef
48.
49.
Zurück zum Zitat Mafi-Rad M, Luermans JG, Blaauw Y, et al. Feasibility and Acute hemodynamic effect of left ventricular septal pacing by transvenous approach through the interventricular septum. Circ Arrhythm Electrophysiol. 2016;9(3):e003344.PubMedCrossRef Mafi-Rad M, Luermans JG, Blaauw Y, et al. Feasibility and Acute hemodynamic effect of left ventricular septal pacing by transvenous approach through the interventricular septum. Circ Arrhythm Electrophysiol. 2016;9(3):e003344.PubMedCrossRef
50.
Zurück zum Zitat Zhang S, Zhou X, Gold MR. Left bundle branch pacing: JACC Review Topic of the Week. J Am Coll Cardiol. 2019;74(24):3039–49.PubMedCrossRef Zhang S, Zhou X, Gold MR. Left bundle branch pacing: JACC Review Topic of the Week. J Am Coll Cardiol. 2019;74(24):3039–49.PubMedCrossRef
51.
Zurück zum Zitat Zhang W, Huang J, Qi Y, Wang F, Guo L, Shi X, et al. Cardiac resynchronization therapy by left bundle branch area pacing in patients with heart failure and left bundle branch block. Heart Rhythm. 2019;16(12):1783–90.PubMedCrossRef Zhang W, Huang J, Qi Y, Wang F, Guo L, Shi X, et al. Cardiac resynchronization therapy by left bundle branch area pacing in patients with heart failure and left bundle branch block. Heart Rhythm. 2019;16(12):1783–90.PubMedCrossRef
52.
Zurück zum Zitat Vijayaraman P, Huang W. Atrioventricular block at the distal His bundle: electrophysiological insights from left bundle branch pacing. HeartRhythm Case Rep. 2019;4:233–6.CrossRef Vijayaraman P, Huang W. Atrioventricular block at the distal His bundle: electrophysiological insights from left bundle branch pacing. HeartRhythm Case Rep. 2019;4:233–6.CrossRef
53.
Zurück zum Zitat Li X, Li H, Ma W, Ning X, Liang E, Pang K, et al. Permanent left bundle branch area pacing for atrioventricular block: feasibility, safety, and acute effect. Heart Rhythm. 2019;16(12):1766–73.PubMedCrossRef Li X, Li H, Ma W, Ning X, Liang E, Pang K, et al. Permanent left bundle branch area pacing for atrioventricular block: feasibility, safety, and acute effect. Heart Rhythm. 2019;16(12):1766–73.PubMedCrossRef
54.
Zurück zum Zitat Chen K, Li Y, Dai Y, Sun Q, Luo B, Li C, et al. Comparison of electrocardiogram characteristics and pacing parameters between left bundle branch pacing and right ventricular pacing in patients receiving pacemaker therapy. Europace. 2019;21(4):673–80.PubMedCrossRef Chen K, Li Y, Dai Y, Sun Q, Luo B, Li C, et al. Comparison of electrocardiogram characteristics and pacing parameters between left bundle branch pacing and right ventricular pacing in patients receiving pacemaker therapy. Europace. 2019;21(4):673–80.PubMedCrossRef
55.
Zurück zum Zitat Li Y, Chen K, Dai Y, Li C, Sun Q, Chen R, et al. Left bundle branch pacing for symptomatic bradycardia: Implant success rate, safety, and pacing characteristics. Heart Rhythm. 2019;16(12):1758–65.PubMedCrossRef Li Y, Chen K, Dai Y, Li C, Sun Q, Chen R, et al. Left bundle branch pacing for symptomatic bradycardia: Implant success rate, safety, and pacing characteristics. Heart Rhythm. 2019;16(12):1758–65.PubMedCrossRef
56.
Zurück zum Zitat Hou X, Qian Z, Wang Y, Qiu Y, Chen X, Jiang H, et al. Feasibility and cardiac synchrony of permanent left bundle branch pacing through the interventricular septum. Europace. 2019;21(11):1694–702.PubMedCrossRef Hou X, Qian Z, Wang Y, Qiu Y, Chen X, Jiang H, et al. Feasibility and cardiac synchrony of permanent left bundle branch pacing through the interventricular septum. Europace. 2019;21(11):1694–702.PubMedCrossRef
57.
Zurück zum Zitat Hussein AA, Wilkoff BL. Cardiac implantable electronic device therapy in heart failure. Circ Res. 2019;124(11):1584–97.PubMedCrossRef Hussein AA, Wilkoff BL. Cardiac implantable electronic device therapy in heart failure. Circ Res. 2019;124(11):1584–97.PubMedCrossRef
58.
Zurück zum Zitat Ezzat VA, Lee V, Ahsan S, Chow AW, Segal O, Rowland E, et al. A systematic review of ICD complications in randomised controlled trials versus registries: is our ‘real-world’ data an underestimation? Open Heart. 2015;2(1):e000198.PubMedPubMedCentralCrossRef Ezzat VA, Lee V, Ahsan S, Chow AW, Segal O, Rowland E, et al. A systematic review of ICD complications in randomised controlled trials versus registries: is our ‘real-world’ data an underestimation? Open Heart. 2015;2(1):e000198.PubMedPubMedCentralCrossRef
59.
Zurück zum Zitat Lewis GF, Gold MR. Safety and Efficacy of the Subcutaneous Implantable Defibrillator. J Am Coll Cardiol. 2016;67(4):445–54.PubMedCrossRef Lewis GF, Gold MR. Safety and Efficacy of the Subcutaneous Implantable Defibrillator. J Am Coll Cardiol. 2016;67(4):445–54.PubMedCrossRef
60.
Zurück zum Zitat Brouwer TF, Yilmaz D, Lindeboom R, Buiten MS, Olde Nordkamp LRA, Schalij MJ, et al. Long-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy. J Am Coll Cardiol. 2016;68(19):2047–55.PubMedCrossRef Brouwer TF, Yilmaz D, Lindeboom R, Buiten MS, Olde Nordkamp LRA, Schalij MJ, et al. Long-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy. J Am Coll Cardiol. 2016;68(19):2047–55.PubMedCrossRef
61.
Zurück zum Zitat Kaya E, Rassaf T, Wakili R. Subcutaneous ICD: Current standards and future perspective. Int J Cardiol Heart Vasc. 2019;24:100409.PubMedPubMedCentral Kaya E, Rassaf T, Wakili R. Subcutaneous ICD: Current standards and future perspective. Int J Cardiol Heart Vasc. 2019;24:100409.PubMedPubMedCentral
62.
Zurück zum Zitat Chieng D, Paul V, Denman R. Current device therapies for sudden cardiac death prevention - the ICD, subcutaneous ICD and eearable ICD. Heart Lung Circ. 2019;28(1):65–75.PubMedCrossRef Chieng D, Paul V, Denman R. Current device therapies for sudden cardiac death prevention - the ICD, subcutaneous ICD and eearable ICD. Heart Lung Circ. 2019;28(1):65–75.PubMedCrossRef
63.
Zurück zum Zitat Basu-Ray I, Liu J, Jia X, Gold M, Ellenbogen K, DiNicolantonio J, et al. Subcutaneous versus transvenous implantable defibrillator therapy: a meta-analysis of case-control studies. JACC Clin Electrophysiol. 2017;3(13):1475–83.PubMedCrossRef Basu-Ray I, Liu J, Jia X, Gold M, Ellenbogen K, DiNicolantonio J, et al. Subcutaneous versus transvenous implantable defibrillator therapy: a meta-analysis of case-control studies. JACC Clin Electrophysiol. 2017;3(13):1475–83.PubMedCrossRef
64.
Zurück zum Zitat Olde Nordkamp LR, Postema PG, Knops RE, et al. Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and complications. Heart Rhythm. 2016;13(2):443–54.PubMedCrossRef Olde Nordkamp LR, Postema PG, Knops RE, et al. Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and complications. Heart Rhythm. 2016;13(2):443–54.PubMedCrossRef
65.
Zurück zum Zitat Quast A-FBE, Baalman SWE, Brouwer TF, Smeding L, Wilde AAM, Burke MC, et al. A novel tool to evaluate the implant position and predict defibrillation success of the subcutaneous implantable cardioverter-defibrillator: the PRAETORIAN score. Heart Rhythm. 2019;16(3):403–10.PubMedCrossRef Quast A-FBE, Baalman SWE, Brouwer TF, Smeding L, Wilde AAM, Burke MC, et al. A novel tool to evaluate the implant position and predict defibrillation success of the subcutaneous implantable cardioverter-defibrillator: the PRAETORIAN score. Heart Rhythm. 2019;16(3):403–10.PubMedCrossRef
66.
Zurück zum Zitat Quast ABE, Baalman SWE, Betts TR, et al. Rationale and design of the PRAETORIAN-DFT trial: a prospective randomized CompArative trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation with and without DeFibrillation testing. Am Heart J. 2019;214:167–74.PubMedCrossRef Quast ABE, Baalman SWE, Betts TR, et al. Rationale and design of the PRAETORIAN-DFT trial: a prospective randomized CompArative trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation with and without DeFibrillation testing. Am Heart J. 2019;214:167–74.PubMedCrossRef
67.
Zurück zum Zitat Knops RE, Olde Nordkamp LRA, Delnoy PHM, et al. Subcutaneous or transvenous defibrillator therapy. N Engl J Med. 2020;383(6):526–36.PubMedCrossRef Knops RE, Olde Nordkamp LRA, Delnoy PHM, et al. Subcutaneous or transvenous defibrillator therapy. N Engl J Med. 2020;383(6):526–36.PubMedCrossRef
68.
Zurück zum Zitat Gold MR, Lambiase PD, El-Chami MF, et al. Primary results from the understanding outcomes with the S-ICD in primary prevention patients with low ejection fraction (UNTOUCHED) trial. Circulation. 2021;143(1):7–17.PubMedCrossRef Gold MR, Lambiase PD, El-Chami MF, et al. Primary results from the understanding outcomes with the S-ICD in primary prevention patients with low ejection fraction (UNTOUCHED) trial. Circulation. 2021;143(1):7–17.PubMedCrossRef
69.
Zurück zum Zitat Chan JYS, Lelakowski J, Murgatroyd FD, Boersma LV, Cao J, Nikolski V, et al. Novel extravascular defibrillation configuration with a coil in the substernal space: the ASD clinical study. JACC Clin Electrophysiol. 2017;3(8):905–10.PubMedCrossRef Chan JYS, Lelakowski J, Murgatroyd FD, Boersma LV, Cao J, Nikolski V, et al. Novel extravascular defibrillation configuration with a coil in the substernal space: the ASD clinical study. JACC Clin Electrophysiol. 2017;3(8):905–10.PubMedCrossRef
70.
Zurück zum Zitat Boersma LVA, Merkely B, Neuzil P, Crozier IG, Akula DN, Timmers L, et al. Therapy from a novel substernal lead: the ASD2 study. JACC Clin Electrophysiol. 2019;5(2):186–96.PubMedCrossRef Boersma LVA, Merkely B, Neuzil P, Crozier IG, Akula DN, Timmers L, et al. Therapy from a novel substernal lead: the ASD2 study. JACC Clin Electrophysiol. 2019;5(2):186–96.PubMedCrossRef
72.
Zurück zum Zitat Cleland JGF, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352(15):1539–49.PubMedCrossRef Cleland JGF, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352(15):1539–49.PubMedCrossRef
73.
Zurück zum Zitat Campbell CM, Kahwash R, Abraham WT. Optimizer Smart in the treatment of moderate-to-severe chronic heart failure. Futur Cardiol. 2020;16(1):13–25.CrossRef Campbell CM, Kahwash R, Abraham WT. Optimizer Smart in the treatment of moderate-to-severe chronic heart failure. Futur Cardiol. 2020;16(1):13–25.CrossRef
74.
Zurück zum Zitat Butter C, Rastogi S, Minden HH, Meyhöfer J, Burkhoff D, Sabbah HN. Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure. J Am Coll Cardiol. 2008;51(18):1784–9.PubMedCrossRef Butter C, Rastogi S, Minden HH, Meyhöfer J, Burkhoff D, Sabbah HN. Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure. J Am Coll Cardiol. 2008;51(18):1784–9.PubMedCrossRef
75.
Zurück zum Zitat Tschöpe C, Kherad B, Klein O, Lipp A, Blaschke F, Gutterman D, et al. Cardiac contractility modulation: mechanisms of action in heart failure with reduced ejection fraction and beyond. Eur J Heart Fail. 2019;21(1):14–22.PubMedCrossRef Tschöpe C, Kherad B, Klein O, Lipp A, Blaschke F, Gutterman D, et al. Cardiac contractility modulation: mechanisms of action in heart failure with reduced ejection fraction and beyond. Eur J Heart Fail. 2019;21(1):14–22.PubMedCrossRef
76.
Zurück zum Zitat Wiegn P, Chan R, Jost C, Saville BR, Parise H, Prutchi D, et al. Safety, Performance, and efficacy of cardiac contractility modulation delivered by the 2-lead optimizer smart system: the FIX-HF-5C2 study. Circ Heart Fail. 2020;13(4):e006512.PubMedCrossRef Wiegn P, Chan R, Jost C, Saville BR, Parise H, Prutchi D, et al. Safety, Performance, and efficacy of cardiac contractility modulation delivered by the 2-lead optimizer smart system: the FIX-HF-5C2 study. Circ Heart Fail. 2020;13(4):e006512.PubMedCrossRef
77.
Zurück zum Zitat Borggrefe MM, Lawo T, Butter C, Schmidinger H, Lunati M, Pieske B, et al. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. Eur Heart J. 2008;29(8):1019–28.PubMedCrossRef Borggrefe MM, Lawo T, Butter C, Schmidinger H, Lunati M, Pieske B, et al. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. Eur Heart J. 2008;29(8):1019–28.PubMedCrossRef
78.
Zurück zum Zitat Kadish A, Nademanee K, Volosin K, et al. A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. Am Heart J. 2011;161(2):329–37.e2.PubMedCrossRef Kadish A, Nademanee K, Volosin K, et al. A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. Am Heart J. 2011;161(2):329–37.e2.PubMedCrossRef
79.
Zurück zum Zitat Abraham WT, Kuck K-H, Goldsmith RL, Lindenfeld JA, Reddy VY, Carson PE, et al. A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation. JACC: Heart Fail. 2018;6(10):874–83. Abraham WT, Kuck K-H, Goldsmith RL, Lindenfeld JA, Reddy VY, Carson PE, et al. A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation. JACC: Heart Fail. 2018;6(10):874–83.
80.
Zurück zum Zitat Anker SD, Borggrefe M, Neuser H, Ohlow MA, Röger S, Goette A, et al. Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction. Eur J Heart Fail. 2019;21(9):1103–13.PubMedCrossRef Anker SD, Borggrefe M, Neuser H, Ohlow MA, Röger S, Goette A, et al. Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction. Eur J Heart Fail. 2019;21(9):1103–13.PubMedCrossRef
81.
Zurück zum Zitat Auricchio A, Prinzen FW. Non-responders to cardiac resynchronization therapy: the magnitude of the problem and the issues. Circ J. 2011;75(3):521–7.PubMedCrossRef Auricchio A, Prinzen FW. Non-responders to cardiac resynchronization therapy: the magnitude of the problem and the issues. Circ J. 2011;75(3):521–7.PubMedCrossRef
82.
Zurück zum Zitat Lund LH, Jurga J, Edner M, Benson L, Dahlström U, Linde C, et al. Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction. Eur Heart J. 2013;34(7):529–39.PubMedCrossRef Lund LH, Jurga J, Edner M, Benson L, Dahlström U, Linde C, et al. Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction. Eur Heart J. 2013;34(7):529–39.PubMedCrossRef
83.
Zurück zum Zitat Röger S, Michels J, Heggemann F, Stach K, Rousso B, Borggrefe M, et al. Long term impact of cardiac contractility modulation on QRS duration. J Electrocardiol. 2014;47(6):936–40.PubMedCrossRef Röger S, Michels J, Heggemann F, Stach K, Rousso B, Borggrefe M, et al. Long term impact of cardiac contractility modulation on QRS duration. J Electrocardiol. 2014;47(6):936–40.PubMedCrossRef
84.
Zurück zum Zitat Kuschyk J, Nägele H, Heinz-Kuck K, et al. Cardiac contractility modulation treatment in patients with symptomatic heart failure despite optimal medical therapy and cardiac resynchronization therapy (CRT). Int J Cardiol. 2019;277:173–7.PubMedCrossRef Kuschyk J, Nägele H, Heinz-Kuck K, et al. Cardiac contractility modulation treatment in patients with symptomatic heart failure despite optimal medical therapy and cardiac resynchronization therapy (CRT). Int J Cardiol. 2019;277:173–7.PubMedCrossRef
85.
Zurück zum Zitat Lin AH, Chin JC, Sicignano NM, Evans AM. Repeat hospitalizations predict mortality in patients with heart failure. Mil Med. 2017;182(9):e1932–e7.PubMedCrossRef Lin AH, Chin JC, Sicignano NM, Evans AM. Repeat hospitalizations predict mortality in patients with heart failure. Mil Med. 2017;182(9):e1932–e7.PubMedCrossRef
86.
Zurück zum Zitat Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377(9766):658–66.PubMedCrossRef Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377(9766):658–66.PubMedCrossRef
87.
Zurück zum Zitat Sandhu AT, Goldhaber-Fiebert JD, Owens DK, Turakhia MP, Kaiser DW, Heidenreich PA. Cost-effectiveness of implantable pulmonary artery pressure monitoring in chronic heart failure. JACC Heart Fail. 2016;4(5):368–75.PubMedPubMedCentralCrossRef Sandhu AT, Goldhaber-Fiebert JD, Owens DK, Turakhia MP, Kaiser DW, Heidenreich PA. Cost-effectiveness of implantable pulmonary artery pressure monitoring in chronic heart failure. JACC Heart Fail. 2016;4(5):368–75.PubMedPubMedCentralCrossRef
88.
Zurück zum Zitat Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891–975.PubMedCrossRef Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891–975.PubMedCrossRef
89.
Zurück zum Zitat Veenis JF, Brugts JJ. Remote monitoring of chronic heart failure patients: invasive versus non-invasive tools for optimising patient management. Neth Hear J. 2020;28(1):3–13.CrossRef Veenis JF, Brugts JJ. Remote monitoring of chronic heart failure patients: invasive versus non-invasive tools for optimising patient management. Neth Hear J. 2020;28(1):3–13.CrossRef
90.
Zurück zum Zitat van Veldhuisen DJ, Braunschweig F, Conraads V, Ford I, Cowie MR, Jondeau G, et al. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation. 2011;124(16):1719–26.PubMedCrossRef van Veldhuisen DJ, Braunschweig F, Conraads V, Ford I, Cowie MR, Jondeau G, et al. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation. 2011;124(16):1719–26.PubMedCrossRef
91.
Zurück zum Zitat Boriani G, Da Costa A, Quesada A, et al. Effects of remote monitoring on clinical outcomes and use of healthcare resources in heart failure patients with biventricular defibrillators: results of the MORE-CARE multicentre randomized controlled trial. Eur J Heart Fail. 2017;19(3):416–25.PubMedCrossRef Boriani G, Da Costa A, Quesada A, et al. Effects of remote monitoring on clinical outcomes and use of healthcare resources in heart failure patients with biventricular defibrillators: results of the MORE-CARE multicentre randomized controlled trial. Eur J Heart Fail. 2017;19(3):416–25.PubMedCrossRef
92.
Zurück zum Zitat Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM Jr, Magalski A, et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol. 2008;51(11):1073–9.PubMedCrossRef Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM Jr, Magalski A, et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol. 2008;51(11):1073–9.PubMedCrossRef
93.
Zurück zum Zitat Abraham William T, Perl L. Implantable hemodynamic monitoring for heart failure patients. J Am Coll Cardiol. 2017;70(3):389–98.PubMedCrossRef Abraham William T, Perl L. Implantable hemodynamic monitoring for heart failure patients. J Am Coll Cardiol. 2017;70(3):389–98.PubMedCrossRef
94.
Zurück zum Zitat Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation. 1998;97(21):2154–9.PubMedCrossRef Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation. 1998;97(21):2154–9.PubMedCrossRef
95.
Zurück zum Zitat Corrà U, Pistono M, Mezzani A, et al. Sleep and exertional periodic breathing in chronic heart failure: prognostic importance and interdependence. Circulation. 2006;113(1):44–50.PubMedCrossRef Corrà U, Pistono M, Mezzani A, et al. Sleep and exertional periodic breathing in chronic heart failure: prognostic importance and interdependence. Circulation. 2006;113(1):44–50.PubMedCrossRef
96.
Zurück zum Zitat Ding N, Zhang X. Transvenous phrenic nerve stimulation, a novel therapeutic approach for central sleep apnea. J Thorac Dis. 2018;10(3):2005–10.PubMedPubMedCentralCrossRef Ding N, Zhang X. Transvenous phrenic nerve stimulation, a novel therapeutic approach for central sleep apnea. J Thorac Dis. 2018;10(3):2005–10.PubMedPubMedCentralCrossRef
97.
Zurück zum Zitat Fox H, Oldenburg O, Javaheri S, et al. Long-term efficacy and safety of phrenic nerve stimulation for the treatment of central sleep apnea. Sleep. 2019;42(11):zsz158. Fox H, Oldenburg O, Javaheri S, et al. Long-term efficacy and safety of phrenic nerve stimulation for the treatment of central sleep apnea. Sleep. 2019;42(11):zsz158.
98.
Zurück zum Zitat Costanzo MR, Ponikowski P, Javaheri S, Augostini R, Goldberg L, Holcomb R, et al. Transvenous neurostimulation for central sleep apnoea: a randomised controlled trial. Lancet. 2016;388(10048):974–82.PubMedCrossRef Costanzo MR, Ponikowski P, Javaheri S, Augostini R, Goldberg L, Holcomb R, et al. Transvenous neurostimulation for central sleep apnoea: a randomised controlled trial. Lancet. 2016;388(10048):974–82.PubMedCrossRef
99.
Zurück zum Zitat Costanzo MR, Ponikowski P, Javaheri S, Augostini R, Goldberg LR, Holcomb R, et al. Sustained 12 month benefit of phrenic nerve stimulation for central sleep apnea. Am J Cardiol. 2018;121(11):1400–8.PubMedCrossRef Costanzo MR, Ponikowski P, Javaheri S, Augostini R, Goldberg LR, Holcomb R, et al. Sustained 12 month benefit of phrenic nerve stimulation for central sleep apnea. Am J Cardiol. 2018;121(11):1400–8.PubMedCrossRef
100.
Zurück zum Zitat Arzt M, Floras JS, Logan AG, Kimoff RJ, Series F, Morrison D, et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation. 2007;115(25):3173–80.PubMedCrossRef Arzt M, Floras JS, Logan AG, Kimoff RJ, Series F, Morrison D, et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation. 2007;115(25):3173–80.PubMedCrossRef
101.
Zurück zum Zitat Jilek C, Krenn M, Sebah D, Obermeier R, Braune A, Kehl V, et al. Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study. Eur J Heart Fail. 2011;13(1):68–75.PubMedCrossRef Jilek C, Krenn M, Sebah D, Obermeier R, Braune A, Kehl V, et al. Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study. Eur J Heart Fail. 2011;13(1):68–75.PubMedCrossRef
102.
Zurück zum Zitat Javaheri S, Shukla R, Zeigler H, Wexler L. Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol. 2007;49(20):2028–34.PubMedCrossRef Javaheri S, Shukla R, Zeigler H, Wexler L. Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol. 2007;49(20):2028–34.PubMedCrossRef
103.
Zurück zum Zitat Costanzo MR, Ponikowski P, Coats A, Javaheri S, Augostini R, Goldberg LR, et al. Phrenic nerve stimulation to treat patients with central sleep apnoea and heart failure. Eur J Heart Fail. 2018;20(12):1746–54.PubMedCrossRef Costanzo MR, Ponikowski P, Coats A, Javaheri S, Augostini R, Goldberg LR, et al. Phrenic nerve stimulation to treat patients with central sleep apnoea and heart failure. Eur J Heart Fail. 2018;20(12):1746–54.PubMedCrossRef
Metadaten
Titel
Innovations in Cardiac Implantable Electronic Devices
verfasst von
Khurrum Khan
Jitae A. Kim
Andra Gurgu
Muzamil Khawaja
Dragos Cozma
Mihail G. Chelu
Publikationsdatum
02.03.2021
Verlag
Springer US
Erschienen in
Cardiovascular Drugs and Therapy / Ausgabe 4/2022
Print ISSN: 0920-3206
Elektronische ISSN: 1573-7241
DOI
https://doi.org/10.1007/s10557-021-07163-5

Weitere Artikel der Ausgabe 4/2022

Cardiovascular Drugs and Therapy 4/2022 Zur Ausgabe

Neu im Fachgebiet Kardiologie

Nach dem Nitrospray fünf Minuten mit der Kardio-CT warten!

19.07.2024 Koronare Herzerkrankung Nachrichten

Nach Verabreichung von sublingualem Nitrospray vor einer CT-Koronarangiografie sollte man unbedingt die in Leitlinien empfohlene Wartezeit einhalten, rät ein kardiologisches Team aus Belgien.

Welche Antikoagulation bei Vorhofflimmern und Leberzirrhose?

19.07.2024 Leberzirrhose Nachrichten

Bei einer Auswertung von US-Versicherungsdaten ging es um die Frage, welche Antikoagulation –  Apixaban, Rivaroxaban oder Warfarin – bei Personen mit Leberzirrhose und Vorhofflimmern unterm Strich die beste Prophylaxe-Option ist.     

Mehrgefäßstenosen einzeitig oder zweizeitig eröffnen?

18.07.2024 Gefäßstenosen Nachrichten

Nach einem Herzinfarkt mit Mehrgefäßerkrankung sind bessere Ergebnisse zu erwarten, wenn alle stenotischen Abschnitte revaskularisiert werden. Sollte das in einer oder in mehreren Sitzungen geschehen? Eine Metaanalyse gibt eine klare Antwort.

Erste zielgerichtete Therapie zur Behandlung der hypertrophen obstruktiven Kardiomyopathie

18.07.2024 Kardiomyopathie Nachrichten

Mit Mavacamten von Bristol Myers Squibb ist erstmals eine zielgerichtete Therapie der hypertrophen obstruktiven Kardiomyopathie (HOCM) verfügbar. Der Myosin-Inhibitor verhindert die bei HOCM übermäßige Bildung von Aktin-Myosin-Querbrücken und verbessert die Symptomatik und die Lebensqualität von Betroffenen.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.